ERBB2 c.2325_2326insTATGTAATGGCA ;(p.Y772_A775dup)

Variant ID: 17-37880996-T-TTATGTAATGGCA

NM_004448.2(ERBB2):c.2325_2326insTATGTAATGGCA;(p.Y772_A775dup)

This variant was identified in 63 publications

View GRCh38 version.




Publications:


Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants.

Frontiers In Oncology
Hallermayr, Ariane A; Neuhann, Teresa M TM; Steinke-Lange, Verena V; Scharf, Florentine F; Laner, Andreas A; Ewald, Roland R; Liesfeld, Ben B; Holinski-Feder, Elke E; Pickl, Julia M A JMA
Publication Date: 2022

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 36636551
Variant Present in the following documents:
  • Table_1.xlsx, sheet 1
  • Table_1.xlsx, sheet 7
  • Table_1.xlsx, sheet 10
View BVdb publication page



Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial.

Journal For Immunotherapy Of Cancer
Han, Xiao X; Tang, Xiaoyong X; Zhu, Hui H; Zhu, Dongyuan D; Zhang, Xiqin X; Meng, Xiangjiao X; Hua, Ying Y; Wang, Zhongtang Z; Zhang, Yan Y; Huang, Wei W; Wang, Linlin L; Yuan, Shuanghu S; Zhang, Pinliang P; Gong, Heyi H; Sun, Yulan Y; Zhang, Yingjie Y; Liu, Zengjun Z; Dong, Xiaomeng X; Gai, Fei F; Huang, Zhan Z; Zhu, Changbin C; Guo, Jun J; Wang, Zhehai Z
Publication Date: 2022-12

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 36600554
Variant Present in the following documents:
  • jitc-2022-004952supp005.pdf
View BVdb publication page



Targeting the EGF receptor family in non-small cell lung cancer-increased complexity and future perspectives.

Cancer Biology & Medicine
Boch, Tobias T; Köhler, Jens J; Janning, Melanie M; Loges, Sonja S
Publication Date: 2022-12-05

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 36476337
Variant Present in the following documents:
  • Main text
  • cbm-19-1543.pdf
View BVdb publication page



Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer.

Plos One
Chow, Yock Ping YP; Zainul Abidin, Norziha N; Kow, Ken Siong KS; Tho, Lye Mun LM; Wong, Chieh Lee CL
Publication Date: 2022

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 36256645
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma.

Frontiers In Oncology
Yin, Xiang-Qian XQ; Yin, Xue-Hui XH; Yu, Ya-Qin YQ; Xu, Lang L; Zhang, Mao M
Publication Date: 2022

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 35936718
Variant Present in the following documents:
  • Table_4.xlsx, sheet 2
View BVdb publication page



The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report.

Translational Cancer Research
He, Yueming Y; Huang, Hong H; Xu, Meng M; Fu, Zhihui Z; Zhang, Xiang'e X; Chen, Xiaoyan X; Guo, Weifeng W
Publication Date: 2022-06

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 35836522
Variant Present in the following documents:
  • Main text
  • tcr-11-06-1819.pdf
View BVdb publication page



Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
Xiang, Chan C; Ji, Chunyu C; Cai, Yiran Y; Teng, Haohua H; Wang, Yulu Y; Zhao, Ruiying R; Shang, Zhanxian Z; Guo, Lianying L; Chen, Shengnan S; Lizaso, Analyn A; Lin, Jing J; Wang, Haozhe H; Li, Bing B; Zhang, Zhou Z; Zhao, Jikai J; Wei, Jinzhi J; Liu, Jiaxin J; Zhu, Lei L; Fang, Wentao W; Han, Yuchen Y
Publication Date: 2022-09

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 35641658
Variant Present in the following documents:
  • Main text
  • 41379_2022_Article_1076.pdf
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.

International Journal Of Molecular Medicine
Chevrier, Sandy S; Brasselet, Astrid A; Carnet, Marion M; Chevriaux, Angélique A; Gibeaud, Anne A; Jourdain, Marine M; Mananet, Hugo H; Truntzer, Caroline C; Beltjens, Françoise F; Charon-Barra, Céline C; Arnould, Laurent L; Albuisson, Juliette J; Comte, Anthony A; Derangère, Valentin V; Goussot, Vincent V; Boidot, Romain R
Publication Date: 2022-05

Variant appearance in text: ERBB2: Ala775_Gly776insTyrValMetAla
PubMed Link: 35244186
Variant Present in the following documents:
  • Supplementary_Data3.xlsx, sheet 1
View BVdb publication page



Consensus for HER2 alterations testing in non-small-cell lung cancer.

Esmo Open
Ren, S S; Wang, J J; Ying, J J; Mitsudomi, T T; Lee, D H DH; Wang, Z Z; Chu, Q Q; Mack, P C PC; Cheng, Y Y; Duan, J J; Fan, Y Y; Han, B B; Hui, Z Z; Liu, A A; Liu, J J; Lu, Y Y; Ma, Z Z; Shi, M M; Shu, Y Y; Song, Q Q; Song, X X; Song, Y Y; Wang, C C; Wang, X X; Wang, Z Z; Xu, Y Y; Yao, Y Y; Zhang, L L; Zhao, M M; Zhu, B B; Zhang, J J; Zhou, C C; Hirsch, F R FR
Publication Date: 2022-02

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 35149428
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



The efficacy of ado-trastuzumab emtansine in patients with ERBB2-aberrant non-small cell lung cancer: a systematic review.

Translational Cancer Research
Huang, Xiu X; Jin, Rui R; Lou, Lingyun L; Zhao, Jie J; Xia, Lexin L; Zhao, Jing J; Li, Wen W; Xu, Zhihao Z; Xia, Yang Y
Publication Date: 2020-08

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 35117816
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy.

Frontiers In Oncology
Liu, Jie J; Xu, Wang-Yang WY; Ye, Maosong M; Liu, Zilong Z; Li, Chun C
Publication Date: 2021

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 34970478
Variant Present in the following documents:
  • Main text
  • fonc-11-726547.pdf
View BVdb publication page



Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature.

World Journal Of Surgical Oncology
Xu, Huanhuan H; Liang, Qi Q; Xu, Xian X; Tan, Shanyue S; Wang, Sumeng S; Liu, Yiqian Y; Liu, Lingxiang L
Publication Date: 2021-11-18

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 34794435
Variant Present in the following documents:
  • Main text
  • 12957_2021_Article_2444.pdf
View BVdb publication page



Targeted Sequencing Revealed Distinct Mutational Profiles of Ocular and Extraocular Sebaceous Carcinomas.

Cancers
Na, Hee Young HY; Park, Jeong Hwan JH; Shin, Sun Ah SA; Lee, Sejoon S; Lee, Heonyi H; Chae, Heejoon H; Choung, HoKyung H; Kim, Namju N; Chung, Jin-Haeng JH; Kim, Ji Eun JE
Publication Date: 2021-09-26

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 34638295
Variant Present in the following documents:
  • Main text
  • cancers-13-04810.pdf
View BVdb publication page



Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.

Radiation Oncology (London, England)
Schneider, Raik R; Gademann, Günther G; Ochel, Hans-Joachim HJ; Neumann, Karsten K; Jandrig, Burkhard B; Hass, Peter P; Walke, Mathias M; Schostak, Martin M; Brunner, Thomas T; Christoph, Frank F
Publication Date: 2021-07-28

Variant appearance in text: ERBB2: E770_A771insAYVM
PubMed Link: 34321039
Variant Present in the following documents:
  • Main text
  • 13014_2021_Article_1859.pdf
View BVdb publication page



Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.

International Journal Of Molecular Sciences
Rebuzzi, Sara Elena SE; Zullo, Lodovica L; Rossi, Giovanni G; Grassi, Massimiliano M; Murianni, Veronica V; Tagliamento, Marco M; Prelaj, Arsela A; Coco, Simona S; Longo, Luca L; Dal Bello, Maria Giovanna MG; Alama, Angela A; Dellepiane, Chiara C; Bennicelli, Elisa E; Malapelle, Umberto U; Genova, Carlo C
Publication Date: 2021-03-05

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 33807876
Variant Present in the following documents:
  • Main text
View BVdb publication page



Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.

International Journal Of Clinical Oncology
Chang, Gee-Chen GC; Lam, David Chi-Leung DC; Tsai, Chun-Ming CM; Chen, Yuh-Min YM; Shih, Jin-Yuan JY; Aggarwal, Shyam S; Wang, Shuhang S; Kim, Sang-We SW; Kim, Young-Chul YC; Wahid, Ibrahim I; Li, Rubi R; Lim, Darren Wan-Teck DW; Sriuranpong, Virote V; Chan, Raymond Tsz-Tong RT; Lorence, Robert M RM; Carriere, Philippe P; Raabe, Christina C; Cseh, Agnieszka A; Park, Keunchil K
Publication Date: 2021-05

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 33783657
Variant Present in the following documents:
  • Main text
  • 10147_2021_Article_1869.pdf
View BVdb publication page



Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature.

Thoracic Cancer
Asselta, Rosanna R; Di Tommaso, Luca L; Perrino, Matteo M; Destro, Annarita A; Giordano, Laura L; Cardamone, Giulia G; Rubino, Luca L; Santoro, Armando A; Duga, Stefano S; Zucali, Paolo Andrea PA
Publication Date: 2021-05

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 33704917
Variant Present in the following documents:
  • TCA-12-1271-s003.xls, sheet 1
View BVdb publication page



Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Molecular Cancer
Fang, Wenfeng W; Jin, Haoxuan H; Zhou, Huaqiang H; Hong, Shaodong S; Ma, Yuxiang Y; Zhang, Yaxiong Y; Su, Xiaofan X; Chen, Longyun L; Yang, Yunpeng Y; Xu, Shengqiang S; Liao, Yuwei Y; He, Yuming Y; Zhao, Hongyun H; Huang, Yan Y; Gao, Zhibo Z; Zhang, Li L
Publication Date: 2021-02-23

Variant appearance in text: ERBB2: Ala775_Gly776insTyrValMetAla
PubMed Link: 33622313
Variant Present in the following documents:
  • 12943_2021_1331_MOESM3_ESM.xlsx, sheet 4
View BVdb publication page



[Research Progress of Targeted Therapy for HER2 Gene 
in Advanced Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Kong, Lingping L; Zhong, Diansheng D
Publication Date: 2020-12-20

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 33357319
Variant Present in the following documents:
  • Main text
View BVdb publication page



Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Estrada-Bernal, Adriana A; Le, Anh T AT; Doak, Andrea E AE; Tirunagaru, Vijaya G VG; Silva, Shevan S; Bull, Matthew R MR; Smaill, Jeff B JB; Patterson, Adam V AV; Kim, Chul C; Liu, Stephen V SV; Doebele, Robert C RC
Publication Date: 2021-03-01

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 33355298
Variant Present in the following documents:
  • Main text
View BVdb publication page



Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.

Cells
Belloum, Yassine Y; Janning, Melanie M; Mohme, Malte M; Simon, Ronald R; Kropidlowski, Jolanthe J; Sartori, Alexander A; Irwin, Darryl D; Westphal, Manfred M; Lamszus, Katrin K; Loges, Sonja S; Riethdorf, Sabine S; Pantel, Klaus K; Wikman, Harriet H
Publication Date: 2020-10-22

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 33105541
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study.

Cancers
Lamy, Pierre-Jean PJ; van der Leest, Paul P; Lozano, Nicolas N; Becht, Catherine C; Duboeuf, Frédérique F; Groen, Harry J M HJM; Hilgers, Werner W; Pourel, Nicolas N; Rifaela, Naomi N; Schuuring, Ed E; Alix-Panabières, Catherine C
Publication Date: 2020-10-16

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 33081150
Variant Present in the following documents:
  • cancers-12-03002-s001.pdf
View BVdb publication page



Catalog of Lung Cancer Gene Mutations Among Chinese Patients.

Frontiers In Oncology
Xue, Xinying X; Asuquo, Idorenyin I; Hong, Lei L; Gao, Jie J; Dong, Zhouhuan Z; Pang, Li L; Jiang, Tianjiao T; Meng, Mingming M; Fan, Jingbo J; Wen, Jiaxin J; Deng, Hui H; Zang, Xuelei X; Ma, Xidong X; Guo, Rui R; Qin, Chong C; Meng, Yao Y; Ma, Heji H; Han, Jun J; Wang, Haijiao H; Xue, Zhiqiang Z; Zhao, Dahai D; Lin, Dongliang D; Pan, Lei L
Publication Date: 2020

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 32850378
Variant Present in the following documents:
  • Main text
View BVdb publication page



HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib.

Frontiers In Oncology
Zhang, Xinyong X; Lv, Jialin J; Wu, Yuhua Y; Qin, Na N; Ma, Li L; Li, Xi X; Nong, Jingying J; Zhang, Hui H; Zhang, Quan Q; Yang, Xinjie X; Shi, Huibo H; Wang, Jinghui J; Zhang, Shucai S
Publication Date: 2020

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 32850330
Variant Present in the following documents:
  • Main text
  • fonc-10-01162.pdf
View BVdb publication page



Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.

Journal Of Translational Medicine
Li, Jiaping J; Jiang, Wei W; Wei, Jinwang J; Zhang, Jianwei J; Cai, Linbo L; Luo, Minjie M; Wang, Zhan Z; Sun, Wending W; Wang, Shengzhou S; Wang, Chen C; Dai, Chun C; Liu, Jun J; Wang, Guan G; Wang, Jiping J; Xu, Qiang Q; Deng, Yanhong Y
Publication Date: 2020-08-01

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 32738923
Variant Present in the following documents:
  • 12967_2020_2449_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Genetic Markers in Lung Cancer Diagnosis: A Review.

International Journal Of Molecular Sciences
Wadowska, Katarzyna K; Bil-Lula, Iwona I; Trembecki, Łukasz Ł; Śliwińska-Mossoń, Mariola M
Publication Date: 2020-06-27

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 32604993
Variant Present in the following documents:
  • Main text
  • ijms-21-04569.pdf
View BVdb publication page



Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib.

Frontiers In Oncology
Yuan, Bo B; Zhao, Jun J; Zhou, Chengzhi C; Wang, Xiumei X; Zhu, Bo B; Zhuo, Minglei M; Dong, Xilin X; Feng, Jiemei J; Yi, Cuihua C; Yang, Yunpeng Y; Zhang, Hua H; Zhou, Wangyan W; Chen, Zhengtang Z; Yang, Sheng S; Ai, Xinghao X; Chen, Kehe K; Cui, Xuefan X; Liu, Difa D; Shi, Chunmei C; Wu, Wei W; Zhang, Yanjun Y; Chang, Lianpeng L; Li, Jin J; Chen, Rongrong R; Yang, Shuanying S
Publication Date: 2020

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 32477948
Variant Present in the following documents:
  • Main text
  • fonc-10-00729.pdf
View BVdb publication page



Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.

International Journal Of Clinical And Experimental Pathology
Chen, Lingfeng L; Chen, Minyan M; Lin, Jie J; Chen, Xiaoyan X; Yu, Xunbin X; Chen, Zhizhong Z; Jin, Long L
Publication Date: 2020

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 32269691
Variant Present in the following documents:
  • Main text
View BVdb publication page



A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer.

Nature Genetics
Wagner, Alex H AH; Walsh, Brian B; Mayfield, Georgia G; Tamborero, David D; Sonkin, Dmitriy D; Krysiak, Kilannin K; Deu-Pons, Jordi J; Duren, Ryan P RP; Gao, Jianjiong J; McMurry, Julie J; Patterson, Sara S; Del Vecchio Fitz, Catherine C; Pitel, Beth A BA; Sezerman, Ozman U OU; Ellrott, Kyle K; Warner, Jeremy L JL; Rieke, Damian T DT; Aittokallio, Tero T; Cerami, Ethan E; Ritter, Deborah I DI; Schriml, Lynn M LM; Freimuth, Robert R RR; Haendel, Melissa M; Raca, Gordana G; Madhavan, Subha S; Baudis, Michael M; Beckmann, Jacques S JS; Dienstmann, Rodrigo R; Chakravarty, Debyani D; Li, Xuan Shirley XS; Mockus, Susan S; Elemento, Olivier O; Schultz, Nikolaus N; Lopez-Bigas, Nuria N; Lawler, Mark M; Goecks, Jeremy J; Griffith, Malachi M; Griffith, Obi L OL; Margolin, Adam A AA; ,
Publication Date: 2020-04

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 32246132
Variant Present in the following documents:
  • Main text
  • 41588_2020_Article_603.pdf
View BVdb publication page



Treatment outcome and clinical characteristics of HER2 mutated advanced non-small cell lung cancer patients in China.

Thoracic Cancer
Xu, Fei F; Yang, Guangjian G; Xu, Haiyan H; Yang, Lu L; Qiu, Weini W; Wang, Yan Y
Publication Date: 2020-03

Variant appearance in text: HER2: Ala775_Gly776insTyrValMetAla
PubMed Link: 31975535
Variant Present in the following documents:
  • Main text
  • TCA-11-679.pdf
View BVdb publication page



Development and validation of a targeted gene sequencing panel for application to disparate cancers.

Scientific Reports
McCabe, Mark J MJ; Gauthier, Marie-Emilie A MA; Chan, Chia-Ling CL; Thompson, Tanya J TJ; De Sousa, Sunita M C SMC; Puttick, Clare C; Grady, John P JP; Gayevskiy, Velimir V; Tao, Jiang J; Ying, Kevin K; Cipponi, Arcadi A; Deng, Niantao N; Swarbrick, Alex A; Thomas, Melissa L ML; Lord, Reginald V RV; Johns, Amber L AL; Kohonen-Corish, Maija M; O'Toole, Sandra A SA; Clark, Jonathan J; Mueller, Simon A SA; Gupta, Ruta R; McCormack, Ann I AI; Dinger, Marcel E ME; Cowley, Mark J MJ; ,
Publication Date: 2019-11-19

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 31745186
Variant Present in the following documents:
  • 41598_2019_52000_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Clinical & Translational Oncology : Official Publication Of The Federation Of Spanish Oncology Societies And Of The National Cancer Institute Of Mexico
Garrido, P P; Conde, E E; de Castro, J J; Gómez-Román, J J JJ; Felip, E E; Pijuan, L L; Isla, D D; Sanz, J J; Paz-Ares, L L; López-Ríos, F F
Publication Date: 2020-07

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 31598903
Variant Present in the following documents:
  • Main text
  • 12094_2019_Article_2218.pdf
View BVdb publication page



Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements.

The Journal Of Molecular Diagnostics : Jmd
He, Hua-Jun HJ; Stein, Erica V EV; Konigshofer, Yves Y; Forbes, Thomas T; Tomson, Farol L FL; Garlick, Russell R; Yamada, Emiko E; Godfrey, Tony T; Abe, Toshiya T; Tamura, Koji K; Borges, Michael M; Goggins, Michael M; Elmore, Sandra S; Gulley, Margaret L ML; Larson, Jessica L JL; Ringel, Lando L; Haynes, Brian C BC; Karlovich, Chris C; Williams, P Mickey PM; Garnett, Aaron A; Ståhlberg, Anders A; Filges, Stefan S; Sorbara, Lynn L; Young, Mathew R MR; Srivastava, Sudhir S; Cole, Kenneth D KD
Publication Date: 2019-07

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 31055023
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Targeted Single Primer Enrichment Sequencing with Single End Duplex-UMI.

Scientific Reports
Peng, Quan Q; Xu, Chang C; Kim, Daniel D; Lewis, Marcus M; DiCarlo, John J; Wang, Yexun Y
Publication Date: 2019-03-18

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 30886209
Variant Present in the following documents:
  • 41598_2019_41215_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



Update on emerging biomarkers in lung cancer.

Journal Of Thoracic Disease
Bernicker, Eric H EH; Allen, Timothy Craig TC; Cagle, Phillip T PT
Publication Date: 2019-01

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 30775031
Variant Present in the following documents:
  • Main text
View BVdb publication page



Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.

Diagnostic Pathology
Grosse, Alexandra A; Grosse, Claudia C; Rechsteiner, Markus M; Soltermann, Alex A
Publication Date: 2019-02-11

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 30744664
Variant Present in the following documents:
  • Main text
  • 13000_2019_Article_789.pdf
View BVdb publication page



Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study.

European Journal Of Cancer (Oxford, England : 1990)
Lai, W Victoria WV; Lebas, Louisiane L; Barnes, Tristan A TA; Milia, Julie J; Ni, Ai A; Gautschi, Oliver O; Peters, Solange S; Ferrara, Roberto R; Plodkowski, Andrew J AJ; Kavanagh, John J; Sabari, Joshua K JK; Clarke, Stephen J SJ; Pavlakis, Nick N; Drilon, Alexander A; Rudin, Charles M CM; Arcila, Maria E ME; Leighl, Natasha B NB; Shepherd, Frances A FA; Kris, Mark G MG; Mazières, Julien J; Li, Bob T BT
Publication Date: 2019-03

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 30685684
Variant Present in the following documents:
  • Main text
View BVdb publication page



High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.

Cancers
Rosa-Rosa, Juan Manuel JM; Caniego-Casas, Tamara T; Leskela, Susanna S; Cristobal, Eva E; González-Martínez, Silvia S; Moreno-Moreno, Esther E; López-Miranda, Elena E; Holgado, Esther E; Pérez-Mies, Belén B; Garrido, Pilar P; Palacios, José J
Publication Date: 2019-01-11

Variant appearance in text: ERBB2: A775_G776insYVMA
PubMed Link: 30641862
Variant Present in the following documents:
  • Main text
  • cancers-11-00074.pdf
View BVdb publication page



HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology
Wang, Y Y; Jiang, T T; Qin, Z Z; Jiang, J J; Wang, Q Q; Yang, S S; Rivard, C C; Gao, G G; Ng, T L TL; Tu, M M MM; Yu, H H; Ji, H H; Zhou, C C; Ren, S S; Zhang, J J; Bunn, P P; Doebele, R C RC; Camidge, D R DR; Hirsch, F R FR
Publication Date: 2019-03-01

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 30596880
Variant Present in the following documents:
  • Main text
View BVdb publication page



Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature.

Thoracic Cancer
Shi, Yuequan Y; Wang, Mengzhao M
Publication Date: 2018-12

Variant appearance in text: HER2: A775_G776insYVMA
PubMed Link: 30379401
Variant Present in the following documents:
  • Main text
View BVdb publication page